MedGen Balance Sheet | StatInvestor

Financial Services » Investing & Securities | MedGen Inc.

MedGen Inc. | Balance Sheet

Fiscal year is October-September. All values USD Thousands.

2013

2014

2015

2016

2017

Cash & Short Term Investments

6.50

2.00

0.70

Inventories

12.80

32.20

3.60

Total Current Assets

19.30

34.20

4.20

Intangible Assets

1,754.20

234.20

Total Assets

1,773.50

268.40

238.40

ST Debt & Current Portion LT Debt

140.30

23.00

140.60

310.00

Accounts Payable

100.90

171.20

Other Current Liabilities

2.50

2.80

82.00

320.40

257.50

Total Current Liabilities

142.80

25.90

222.60

731.30

738.60

Total Liabilities

142.80

25.90

222.60

731.30

738.60

Common Equity (Total)

1,630.50

242.30

15.50

733.30

740.60

Total Shareholders' Equity

1,630.70

242.50

15.80

731.30

738.60

Total Equity

1,630.70

242.50

15.80

731.30

738.60

Liabilities & Shareholders' Equity

1,773.50

268.40

238.40

Preferred Stock (Carrying Value)

0.20

0.30

2.00

About MedGen

View Profile

Address	20 Peachtree Court Holbrook New York 11741 United States
Employees	-
Website	-
Updated	07/08/2019
MedGen, Inc. (New York) engages in the manufacture, sale, and licensing of healthcare products. Its product portfolio includes SNORenz, SNORenz Night-Time, Sombium, Focamine, Wide Awake, Stem Intense, and Relaxapro. The company was founded in October 1996 and is headquartered in Holbrook, NY.